Biosimilars Market- Challenges & Prospects

The global biosimilars market alone  is expected to reach $6.22 Billion by 2020  from  $2.29 Billion in  2015, at a  compound annual growth rate (CAGR) of 22.1% from 2015 to 2020. Geographically, the global biosimilars market is dominated by Europe, followed by Asia-Pacific, Rest of the World (RoW), and North America. However, the Asia-Pacific region is likely to witness the highest growth rate during the forecast period.

There are thought to be more biosimilar products currently in development across the Asia-Pacific region than anywhere else in the world, leading to wealth of opportunities for investigators and patients interested in taking part in biosimilar clinical trials. India, Japan, South Korea, and China are particularly active in biosimilar research efforts. 

The global biosimilars market alone  is expected to reach $6.22 Billion by 2020  from  $2.29 Billion in  2015, at a  compound annual growth rate (CAGR) of 22.1% from 2015 to 2020. Geographically, the global biosimilars market is dominated by Europe, followed by Asia-Pacific, Rest of the World (RoW), and North America. However, the Asia-Pacific region is likely to witness the highest growth rate during the forecast period.

  • Proving the ROI (Return On Investment) of marketing activities
  • QBD (Quality By Design)
  • Long Term Sustainability & PLC (Product Life Cycle)
  • Future of next generation biosimilars
  • SWOT Analysis of Biosimilars
  • Challenging potential & Competing Vs Generics
  • Investment sources and venture capitals

Biosimilars Market- Challenges & Prospects Conference Speakers

Recommended Sessions

Related Journals

Are you interested in